Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
55
HIPO Quote, Financials, Valuation and Earnings
Last price:
$26.31
Seasonality move
:
30.71%
Day range:
$24.64 - $26.74
52-week range:
$7.75 - $34.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.92x
P/B ratio:
1.96x
Volume:
236.3K
Avg. volume:
219K
1-year change:
198.41%
Market cap:
$640.4M
Revenue:
$209.7M
EPS (TTM):
-$5.18
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $51.6M | $91.2M | $119.7M | $209.7M | |
| Revenue Growth (YoY) | -- | -- | 76.74% | 31.25% | 75.19% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $109.2M | $151.4M | $185.8M | $172.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $129.8M | $239.5M | $194.5M | $226M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $26M | $198.9M | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$143.2M | -$367.2M | -$325.2M | -$262.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$1.8M | $700K | $1.3M | $500K | |
| Net Income to Company | -- | -$141.4M | -$367.9M | -$326.5M | -$263M | |
| Minority Interest in Earnings | -- | -$100K | -$3.5M | -$6.9M | -$10.1M | |
| Net Income to Common Excl Extra Items | -- | -$141.5M | -$371.4M | -$333.4M | -$273.1M | |
| Basic EPS (Cont. Ops) | -- | -$40.75 | -$34.11 | -$14.66 | -$11.58 | |
| Diluted EPS (Cont. Ops) | -- | -$40.75 | -$34.11 | -$14.66 | -$11.58 | |
| Weighted Average Basic Share | -- | $3.5M | $10.9M | $22.7M | $23.6M | |
| Weighted Average Diluted Share | -- | $3.5M | $10.9M | $22.7M | $23.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -$117.2M | -$367.2M | -$325.2M | -$262.5M | |
| Revenue (Reported) | -- | $51.6M | $91.2M | $119.7M | $209.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -$117.2M | -$367.2M | -$325.2M | -$262.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13M | $21.3M | $30.7M | $57.7M | $95.5M | |
| Revenue Growth (YoY) | -- | 63.85% | 44.13% | 87.95% | 65.51% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $33.8M | $37.2M | $50.3M | $42.6M | $31M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $39.5M | $46.8M | $12.2M | $57.9M | $50.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $100K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$40.5M | -$29.8M | -$127.2M | -$50.6M | -$5.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.9M | $100K | $300K | -$300K | -- | |
| Net Income to Company | -- | -$29.9M | -$127.5M | -$50.3M | -$5.2M | |
| Minority Interest in Earnings | -- | -$1M | -$1.7M | -$2.8M | -$3.3M | |
| Net Income to Common Excl Extra Items | -$38.6M | -$30.9M | -$129.2M | -$53.1M | -$8.5M | |
| Basic EPS (Cont. Ops) | -$9.82 | -$2.00 | -$5.66 | -$2.24 | -$0.34 | |
| Diluted EPS (Cont. Ops) | -$9.82 | -$2.00 | -$5.66 | -$2.24 | -$0.34 | |
| Weighted Average Basic Share | $3.9M | $15.5M | $22.8M | $23.7M | $25.1M | |
| Weighted Average Diluted Share | $3.9M | $15.5M | $22.8M | $23.7M | $25.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$40.5M | -$29.8M | -$127.2M | -$50.6M | -$5.2M | |
| Revenue (Reported) | $13M | $21.3M | $30.7M | $57.7M | $95.5M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$40.5M | -$29.8M | -$127.2M | -$50.6M | -$5.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $75.6M | $116M | $181M | $334.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $131.5M | $182.3M | $187.7M | $139.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $161.3M | $241.3M | $245.7M | $186.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $100K | $178.5M | $41M | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$362M | -$324.2M | -$283.4M | -$113.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $500K | $1.1M | $700K | $1.2M | |
| Net Income to Company | -- | -- | -$325.3M | -$284.2M | -$114.8M | |
| Minority Interest in Earnings | -- | -$2.2M | -$5.7M | -$9.7M | -$12.2M | |
| Net Income to Common Excl Extra Items | -- | -$364.7M | -$331M | -$293.8M | -$127M | |
| Basic EPS (Cont. Ops) | -- | -$88.01 | -$14.61 | -$12.59 | -$5.18 | |
| Diluted EPS (Cont. Ops) | -- | -$88.01 | -$14.61 | -$12.59 | -$5.18 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -$362M | -$324.2M | -$283.4M | -$113.6M | |
| Revenue (Reported) | -- | $75.6M | $116M | $181M | $334.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -$362M | -$324.2M | -$283.4M | -$113.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13M | $59.2M | $83.9M | $145.2M | $270.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $33.8M | $102.5M | $135.2M | $135.3M | $102.7M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $39.5M | $127.5M | $132.2M | $181.6M | $142.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $100K | $183.1M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$40.5M | -$308.1M | -$265.2M | -$223.4M | -$74.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.9M | $400K | $800K | $200K | $900K | |
| Net Income to Company | -- | -$308.6M | -$266M | -$223.7M | -$75.5M | |
| Minority Interest in Earnings | -- | -$2.1M | -$4.3M | -$7.1M | -$9.2M | |
| Net Income to Common Excl Extra Items | -$38.6M | -$310.6M | -$270.3M | -$230.7M | -$84.7M | |
| Basic EPS (Cont. Ops) | -$9.82 | -$74.25 | -$11.92 | -$9.86 | -$3.45 | |
| Diluted EPS (Cont. Ops) | -$9.82 | -$74.25 | -$11.92 | -$9.86 | -$3.45 | |
| Weighted Average Basic Share | $3.9M | $23.2M | $67.9M | $70.3M | $73.9M | |
| Weighted Average Diluted Share | $3.9M | $23.2M | $67.9M | $70.3M | $73.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$40.5M | -$308.1M | -$265.2M | -$223.4M | -$74.6M | |
| Revenue (Reported) | $13M | $59.2M | $83.9M | $145.2M | $270.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$40.5M | -$308.1M | -$265.2M | -$223.4M | -$74.6M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $452.3M | $775.6M | $194.5M | $142.1M | |
| Short Term Investments | -- | -- | $9.1M | $445.9M | $259.1M | |
| Accounts Receivable, Net | -- | $171.2M | $323.4M | $402.5M | $432.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $129.4M | $231.6M | $327.3M | $346.9M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $774.2M | $1.4B | $1.4B | $1.3B | |
| Property Plant And Equipment | -- | -- | -- | $33M | $45.5M | |
| Long-Term Investments | -- | $56M | $64M | $445.9M | $348.8M | |
| Goodwill | -- | $47.8M | $53.5M | -- | -- | |
| Other Intangibles | -- | $48.6M | $58.1M | $65.7M | $75.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $979.4M | $1.6B | $1.6B | $1.5B | |
| Accounts Payable | -- | $96M | $182.6M | $234.8M | $286.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $98.5M | $182.6M | $234.8M | $286.4M | |
| Long-Term Debt | -- | $273M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $1.2B | $781M | $975.4M | $1.1B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | $100K | -$700K | -$7M | -$2.9M | |
| Common Equity | -- | -$199.6M | $859.6M | $589.9M | $377.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $100K | $2.1M | $3.6M | $6.8M | |
| Total Equity | -- | -$199.5M | $861.7M | $593.5M | $384.7M | |
| Total Liabilities and Equity | -- | $979.4M | $1.6B | $1.6B | $1.5B | |
| Cash and Short Terms | -- | $452.3M | $784.7M | $640.4M | $401.2M | |
| Total Debt | -- | $273M | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $778.7M | $346.5M | $228.4M | $191.2M | |
| Short Term Investments | -- | $12.3M | $221.6M | $253M | $222.3M | |
| Accounts Receivable, Net | -- | $339.7M | $434.9M | $453.9M | $439.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $228.1M | $320.8M | $387M | $301.6M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $1.4B | $1.4B | $1.4B | $1.2B | |
| Property Plant And Equipment | -- | -- | $25.6M | $49.7M | $38.7M | |
| Long-Term Investments | -- | $72M | $330.8M | $330M | $354.3M | |
| Goodwill | -- | $53.2M | -- | -- | -- | |
| Other Intangibles | -- | $55.3M | $64.8M | $70.5M | $74M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $1.7B | $1.6B | $1.6B | $1.5B | |
| Accounts Payable | -- | $162.1M | $242.5M | $321.7M | $285.6M | |
| Accrued Expenses | -- | $9M | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $178.9M | $242.5M | $321.7M | $285.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $754.5M | $991M | $1.2B | $1.2B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -$400K | -$7.8M | -$7.1M | $500K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $2.3M | $4M | $4.3M | $3.7M | |
| Total Equity | -- | $903.7M | $639M | $411.3M | $330.1M | |
| Total Liabilities and Equity | -- | $1.7B | $1.6B | $1.6B | $1.5B | |
| Cash and Short Terms | -- | $791M | $568.1M | $481.4M | $413.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$141.4M | -$367.9M | -$326.5M | -$263M | |
| Depreciation & Amoritzation | -- | $6.7M | $11M | $15.2M | $19.8M | |
| Stock-Based Compensation | -- | $17.2M | $24.3M | $61.9M | $57.5M | |
| Change in Accounts Receivable | -- | -$35.8M | -$172.6M | -$74.5M | -$61M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$65.4M | -$124.5M | -$161.5M | -$92.4M | |
| Capital Expenditures | -- | $9.4M | $17.4M | $19.7M | $46.7M | |
| Cash Acquisitions | -- | -$83.7M | -- | -- | -- | |
| Cash From Investing | -- | -$2.3M | -$30M | -$405.9M | $57.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $365M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$1.8M | |
| Other Financing Activities | -- | -$3.9M | $446.3M | -$10.9M | -$15.6M | |
| Cash From Financing | -- | $518.1M | $480.8M | -$6.8M | -$14.6M | |
| Beginning Cash (CF) | -- | $42M | $492.4M | $818.7M | $244.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $450.4M | $326.3M | -$574.2M | -$49.4M | |
| Ending Cash (CF) | -- | $492.4M | $818.7M | $244.5M | $195.1M | |
| Levered Free Cash Flow | -- | -$74.8M | -$141.9M | -$181.2M | -$139.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$29.9M | -$127.5M | -$50.3M | -$5.2M | |
| Depreciation & Amoritzation | -- | $2.7M | $3.8M | $4.9M | $5.9M | |
| Stock-Based Compensation | -- | $4.5M | $17M | $13.9M | $9M | |
| Change in Accounts Receivable | -- | -$45.8M | -$75.4M | $28.6M | $13.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$50M | -$43M | $1.1M | $46.8M | |
| Capital Expenditures | -- | $3.9M | $5.5M | $4.7M | $3.4M | |
| Cash Acquisitions | -- | -- | -- | -- | $19.2M | |
| Cash From Investing | -- | -$20.6M | $112.5M | $30.8M | -$27.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $456.8M | -$1.2M | -$1.4M | -$9M | |
| Cash From Financing | -- | $483.2M | -$1.1M | -$900K | -$8.2M | |
| Beginning Cash (CF) | -- | $410.2M | $324.5M | $238.4M | $220.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $412.6M | $68.4M | $31M | $10.7M | |
| Ending Cash (CF) | -- | $822.8M | $392.9M | $269.4M | $230.9M | |
| Levered Free Cash Flow | -- | -$53.9M | -$48.5M | -$3.6M | $43.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$325.3M | -$284.2M | -$114.8M | |
| Depreciation & Amoritzation | -- | -- | $14.5M | $18.4M | $22.8M | |
| Stock-Based Compensation | -- | $9.8M | $60.8M | $62.3M | $40.1M | |
| Change in Accounts Receivable | -- | -- | -$106.6M | -$39.5M | -$4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$136.7M | -$74M | $5.4M | |
| Capital Expenditures | -- | $12.7M | $20.9M | $45.7M | $15.1M | |
| Cash Acquisitions | -- | -- | -- | -- | $19.2M | |
| Cash From Investing | -- | -- | -$289.9M | -$35.6M | -$19.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$12.2M | -$15.2M | -$27.8M | |
| Cash From Financing | -- | -- | -$3.3M | -$13.9M | -$24.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$429.9M | -$123.5M | -$38.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$157.6M | -$119.7M | -$9.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$308.6M | -$266M | -$223.7M | -$75.5M | |
| Depreciation & Amoritzation | -- | $7.7M | $11.2M | $14.4M | $17.4M | |
| Stock-Based Compensation | -- | $9.8M | $46.3M | $46.7M | $29.3M | |
| Change in Accounts Receivable | -- | -$184.4M | -$118.4M | -$83.4M | -$26.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$119.2M | -$131.4M | -$43.9M | $53.9M | |
| Capital Expenditures | -- | $12.7M | $16.2M | $42.2M | $10.6M | |
| Cash Acquisitions | -- | -- | -- | -- | $19.2M | |
| Cash From Investing | -- | -$30.8M | -$290.7M | $79.6M | $2.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$1.8M | -- | |
| Other Financing Activities | -- | $451.4M | -$7.1M | -$11.4M | -$23.6M | |
| Cash From Financing | -- | $480.4M | -$3.7M | -$10.8M | -$20.6M | |
| Beginning Cash (CF) | -- | $1.4B | $1.5B | $703.6M | $678.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $330.4M | -$425.8M | $24.9M | $35.8M | |
| Ending Cash (CF) | -- | $1.7B | $1.1B | $728.5M | $714.4M | |
| Levered Free Cash Flow | -- | -$131.9M | -$147.6M | -$86.1M | $43.3M | |
Get HIPO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HIPO
Sector
P/E ratio
--
11.99x
PEG ratio
--
0.36x
P/B ratio
1.96x
1.05x
Price / LTM sales
1.92x
2.55x
Growth Metrics
HIPO
Sector
Revenue growth
65.51%
6.08%
Earnings growth
--
6.45%
Revenue (5-year growth)
--
5.85%
Earnings forecast
-$0.70
$0.56
Profitability
HIPO
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
-35.13%
5.27%
Return on assets
-8.22%
0.98%
Return on equity
-35.13%
9.43%
Earnings Date
Last Earnings Date
Nov
8
Next Earnings Date
Mar
6
Estimated Next Earnings Date
Feb
7
Balance Sheet
HIPO
Sector
Total cash
$413.5M
$615.3M
Short term investments
$259.1M
$408.4M
Total assets
$1.5B
$4.5B
Long term debt
--
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
